Development of Sequence-Optimized Nitroreductase for Retroviral Replicating Vector (RRV)-Mediated Prodrug Activator Gene Therapy in Human Glioma Models

被引：0
|
作者：
Collins, Sara A. [1 ]
Inagaki, Akihito Inagaki [1 ]
Tai, Chien-Kuo [2 ]
Logg, Christopher R. [3 ]
Searle, Peter F. [4 ]
Tangney, Mark [5 ]
Kasahara, Noriyuki [1 ,6 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[2] Natl Chung Cheng Univ, Dept Biomed Sci, Chiayi, Taiwan
[3] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[4] Univ Birmingham, Sch Canc Sci, CR UK Canc Ctr, Birmingham, W Midlands, England
[5] Univ Coll Cork UCC, Cork Canc Res Ctr, Cork, Ireland
[6] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
347
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [21] Dual Prodrug Activator Gene Therapy with Pseudotyped Retroviral Replicating Vectors
    Grosso, James
    Collins, Sara
    Inagaki, Akihito
    Kamath, Priyanka
    Slomovitz, Brian
    Kasahara, Noriyuki
    MOLECULAR THERAPY, 2018, 26 (05) : 210 - 210
  • [22] RETROVIRAL REPLICATING VECTORS PSEUDOTYPED WITH GIBBON APE LEUKEMIA VIRUS ENVELOPE FOR PRODRUG ACTIVATOR GENE THERAPY IN PRECLINICAL GLIOMA MODELS
    Inagaki, Akihito
    Collins, Sara
    Freedman, Alicia
    Montoya, Megan
    Haddad, Alexander
    Barcova, Maria
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2021, 23 : 170 - 170
  • [23] Therapeutic Efficacy of Retroviral Replicating Vector Toca 511 (vocimagene amiretrorepvec) -Mediated Prodrug Activator Gene Therapy for Lung Cancer
    Hiraoka, Kei
    Kushiya, Hiroki
    Suzuki, Tomohiro
    Inoko, Kazuho
    Inagaki, Akihito
    Niwa, Hiroki
    Sasaki, Katsunori
    Nakamura, Toru
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Kasahara, Noriyuki
    Hirano, Satoshi
    MOLECULAR THERAPY, 2023, 31 (04) : 411 - 412
  • [24] Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer
    Kushiya, Hiroki
    Hiraoka, Kei
    Suzuki, Tomohiro
    Inoko, Kazuho
    Inagaki, Akihito
    Niwa, Hiroki
    Sasaki, Katsunori
    Nakamura, Toru
    Tsuchikawa, Takahiro
    Shichinohe, Toshiaki
    Jolly, Douglas J. J.
    Kasahara, Noriyuki
    Hirano, Satoshi
    CANCERS, 2022, 14 (23)
  • [25] Dual-vector prodrug activator gene therapy using two different retroviral replicating vectors
    Kubo, S.
    Takagi-Kimura, M.
    Logg, C. R.
    Hermann, K.
    Kasahara, N.
    HUMAN GENE THERAPY, 2015, 26 (10) : A105 - A106
  • [26] Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors in an Experimental Model of Human Osteosarcoma
    Kubo, Shuji
    Takagi-Kimura, Misato
    Kasahara, Noriyuki
    MOLECULAR THERAPY, 2017, 25 (05) : 61 - 61
  • [27] Improved Retroviral Replicating Vectors for Prodrug-Activator Gene Therapy of Cancer
    Kirk, Kaitlyn
    Hao, Ergeng
    Martinson, Laura
    Kroon, Evert
    Itkin-Ansari, Pamela
    MOLECULAR THERAPY, 2011, 19 (07) : 1361 - 1362
  • [28] ENHANCED THERAPEUTIC EFFICACY OF PRODRUG ACTIVATOR GENE THERAPY WITH A NON-LYTIC RETROVIRAL REPLICATING VECTOR (TOCA 511) COMBINED WITH RADIATION THERAPY IN EXPERIMENTAL GLIOMA
    Takahashi, Masamichi
    Valdes, Gilmer
    Inagaki, Akihito
    Kamijima, Shuichi
    Hiraoka, Kei
    Micewicz, Ewa
    McBride, William H.
    Iwamoto, Keisuke S.
    Hermann, Kip
    Collins, Sara
    Tam, Quincy
    Gruber, Harry E.
    Robbins, Joan M.
    Jolly, Douglas J.
    Kasahara, Noriyuki
    NEURO-ONCOLOGY, 2014, 16
  • [29] Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer
    Isoda, Lisa
    Sonoda-fukuda, Emiko
    Fujino, Hiroaki
    Takarada, Toru
    Hasegawa, Kosei
    Kasahara, Noriyuki
    Kubo, Shuji
    ANTICANCER RESEARCH, 2023, 43 (12) : 5311 - 5317
  • [30] Pseudotyped retroviral replicating vectors for combination prodrug activator gene therapy of ovarian cancer
    Grosso, J.
    Inagaki, A.
    Collins, S. A.
    Matsuura, S.
    Kamath, P. N.
    Ince, T. A.
    Kasahara, N.
    Slomovitz, B.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 95 - 95
12345